In the last decade, methods based on propensity scores (PSs) have been frequently used in multiple sclerosis (MS) studies comparing disease-modifying treatments in nonrandomized observational settings.1 Propensity score adjustment was applied even in situations when all the necessary conditions for its applicability were not satisfied. The PS adjustment can reduce the intrinsic selection bias of nonrandomized studies only if all the confounders are measurable and are at least minimally overlapped between the treatment groups. Sometimes the calendar period or the geographical region of study conduction can be completely nonoverlapping between the compared groups. In such cases, in the causal inference jargon, the positivity assumption, requiring that the probability to receive any of the treatments in all the PS strata is higher than 0, is violated. We will show, with a practical example, the extent of failure of PS adjustment when the positivity assumption is violated.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Signori A, Pellegrini F, Bovis F, Carmisciano L, de Moor C, Sormani MP. Comparison of Placebos and Propensity Score Adjustment in Multiple Sclerosis Nonrandomized Studies. JAMA Neurol. Published online April 20, 2020. doi:10.1001/jamaneurol.2020.0678
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: